(ASAN) Asana - Overview
Sector: Technology | Industry: Software - Application | Exchange: NYSE (USA) | Market Cap: 1.526m USD | Total Return: -57.7% in 12m
Avg Turnover: 39.9M
Qual. Beats: 0
Rev. Trend: 99.2%
Qual. Beats: 0
Warnings
Interest Coverage Ratio -30.1 is critical
Altman Z'' -12.23 < 1.0 - financial distress zone
Overextended 3d
Tailwinds
No distinct edge detected
Asana, Inc. operates a global work management platform designed to orchestrate complex workflows across teams and executive leadership. The company utilizes its proprietary Asana Work Graph data model to map relationships between tasks and strategic goals, recently expanding its suite to include AI Teammates and AI Studio for automated process design. Its product portfolio covers project management, resource allocation, and strategic planning for diverse sectors, including government through its specialized Asana Gov offering.
The business operates within the Software-as-a-Service (SaaS) sector, typically characterized by high gross margins and recurring subscription revenue. Asana employs a hybrid go-to-market strategy that leverages product-led growth-where individual users adopt the tool organically-alongside direct enterprise sales and channel partnerships to scale within large organizations. This multi-layered approach is common in the Systems Software industry to reduce customer acquisition costs while securing long-term enterprise contracts.
Investors can further examine the company’s fundamental health and valuation metrics on ValueRay. Headquartered in San Francisco, Asana serves a broad range of industries including healthcare, financial services, and manufacturing.
- Enterprise customer expansion and seat growth drive long-term recurring revenue
- AI Teammates and workflow automation adoption accelerates premium tier monetization
- Operating margin improvement depends on disciplined sales and marketing spend
- Macroeconomic pressures on corporate IT budgets slow new logo acquisition
- Federal sector penetration through Asana Gov expands total addressable market volume
| Net Income: -189.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 8.90 > 1.0 |
| NWC/Revenue: 11.68% < 20% (prev 25.55%; Δ -13.87% < -1%) |
| CFO/TA 0.11 > 3% & CFO 90.4m > Net Income -189.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (238.4m) vs 12m ago 3.01% < -2% |
| Gross Margin: 89.03% > 18% (prev 0.89%; Δ 8.81k% > 0.5%) |
| Asset Turnover: 91.13% > 50% (prev 81.21%; Δ 9.93% > 0%) |
| Interest Coverage Ratio: -30.10 > 6 (EBITDA TTM -156.2m / Interest Expense TTM 5.92m) |
| A: 0.11 (Total Current Assets 593.3m - Total Current Liabilities 501.0m) / Total Assets 844.1m |
| B: -2.55 (Retained Earnings -2.15b / Total Assets 844.1m) |
| C: -0.21 (EBIT TTM -178.2m / Avg Total Assets 867.8m) |
| D: -3.11 (Book Value of Equity -2.15b / Total Liabilities 690.0m) |
| Altman-Z'' = -12.23 = D |
| DSRI: 1.15 (Receivables 110.3m/87.6m, Revenue 790.8m/723.9m) |
| GMI: 1.00 (GM 89.03% / 89.34%) |
| AQI: 1.08 (AQ_t 0.03 / AQ_t-1 0.03) |
| SGI: 1.09 (Revenue 790.8m / 723.9m) |
| TATA: -0.33 (NI -189.0m - CFO 90.4m) / TA 844.1m) |
| Beneish M = -3.12 (Cap -4..+1) = AA |
As of May 30, 2026, the stock is trading at USD 7.70 with a total of 18,963,910 shares traded.
Over the past week, the price has changed by +21.07%,
over one month by +20.31%,
over three months by +8.45% and
over the past year by -57.67%.
Asana has received a consensus analysts rating of 3.21. Therefore, it is recommended to hold ASAN.
- StrongBuy: 2
- Buy: 3
- Hold: 11
- Sell: 3
- StrongSell: 0
| Analysts Target Price | 9.5 | 23.6% |
P/E Forward = 17.331
P/S = 1.9299
P/B = 9.8724
Revenue TTM = 790.8m USD
EBIT TTM = -178.2m USD
EBITDA TTM = -156.2m USD
Long Term Debt = 35.6m USD (from longTermDebt, two quarters ago)
Short Term Debt = 24.8m USD (from shortTermDebt, last quarter)
Debt = 208.6m USD (from shortLongTermDebtTotal, last quarter) (leases 208.6m already included)
Net Debt = -154.1m USD (calculated: Debt 208.6m - CCE 362.7m)
Enterprise Value = 1.37b USD (1.53b + Debt 208.6m - CCE 362.7m)
Interest Coverage Ratio = -30.10 (Ebit TTM -178.2m / Interest Expense TTM 5.92m)
EV/FCF = 32.72x (Enterprise Value 1.37b / FCF TTM 41.9m)
FCF Yield = 3.06% (FCF TTM 41.9m / Enterprise Value 1.37b)
FCF Margin = 5.30% (FCF TTM 41.9m / Revenue TTM 790.8m)
Net Margin = -23.90% (Net Income TTM -189.0m / Revenue TTM 790.8m)
Gross Margin = 89.03% ((Revenue TTM 790.8m - Cost of Revenue TTM 86.8m) / Revenue TTM)
Gross Margin QoQ = 87.84% (prev 88.90%)
Tobins Q-Ratio = 1.63 (Enterprise Value 1.37b / Total Assets 844.1m)
Interest Expense / Debt = 2.84% (Interest Expense 5.92m / Debt 208.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = -140.8m (EBIT -178.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.14 (Total Current Assets 593.3m / Total Current Liabilities 519.8m)
Debt / Equity = 1.35 (Debt 208.6m / totalStockholderEquity, last quarter 154.1m)
Debt / EBITDA = 0.99 (negative EBITDA) (Net Debt -154.1m / EBITDA -156.2m)
Debt / FCF = -3.68 (Net Debt -154.1m / FCF TTM 41.9m)
Total Stockholder Equity = 200.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -21.78% (Net Income -189.0m / Total Assets 844.1m)
RoE = -8.04% (Net Income TTM -189.0m / Total Stockholder Equity 2.35b)
RoCE = -7.47% (EBIT -178.2m / Capital Employed (Equity 2.35b + L.T.Debt 35.6m))
RoIC = -39.07% (negative operating profit) (NOPAT -140.8m / Invested Capital 360.4m)
WACC = 10.20% (E(1.53b)/V(1.73b) * Re(11.29%) + D(208.6m)/V(1.73b) * Rd(2.84%) * (1-Tc(0.21)))
Discount Rate = 11.29% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 95.56 | Cagr: 3.26%
[DCF] Terminal Value 69.23% ; FCFF base≈41.9m ; Y1≈42.1m ; Y5≈44.6m
[DCF] Fair Price = 4.06 (EV 527.6m - Net Debt -154.1m = Equity 681.7m / Shares 167.8m; r=10.20% [WACC]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.10 | # QB: 0
Revenue Correlation: 99.20 | Revenue CAGR: 11.44% | SUE: 0.30 | # QB: 0
EPS current Quarter (2026-07-31): EPS=0.09 | Chg30d=+0.00% | Revisions=+14% | Analysts=14
EPS current Year (2027-01-31): EPS=0.37 | Chg30d=+0.00% | Revisions=+18% | GrowthEPS=+35.5% | GrowthRev=+8.0%
EPS next Year (2028-01-31): EPS=0.46 | Chg30d=+0.00% | Revisions=+23% | GrowthEPS=+25.3% | GrowthRev=+7.9%
[Analyst] Revisions Ratio: +23%